• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于阿尔茨海默病中5-羟色胺-1A受体的正电子发射断层扫描研究。

A positron emission tomography study of 5-hydroxytryptamine-1A receptors in Alzheimer disease.

作者信息

Lanctôt Krista L, Hussey Doug F, Herrmann Nathan, Black Sandra E, Rusjan Pablo M, Wilson Alan A, Houle Sylvain, Kozloff Nicole, Verhoeff Nicholaas Paul L G, Kapur Shitij

机构信息

Neuropharmacology Research Program and Geriatric Psychiatry, Toronto, Ontario, Canada.

出版信息

Am J Geriatr Psychiatry. 2007 Oct;15(10):888-98. doi: 10.1097/JGP.0b013e3180488325. Epub 2007 Jun 13.

DOI:10.1097/JGP.0b013e3180488325
PMID:17567932
Abstract

OBJECTIVE

The important role of serotonin-1A (5-hydroxytryptamine-1A [5-HT(1A)]) receptors in cognition, behavior, and drug response is increasingly being recognized. Postmortem studies suggest decreased 5-HT(1A) receptors in patients with Alzheimer disease (AD), but this has not been confirmed in vivo. Our primary objective was to assess the extent of 5-HT(1A) receptor losses in mild to moderate AD.

METHODS

The authors examined 5-HT(1A) receptors in 10 patients with mild to moderate AD and 10 healthy volunteers with the same sex and similar age using positron emission tomography imaging with the selective 5-HT(1A) receptor radioligand, [(11)C]WAY-100635. Regions of interest (ROIs) were manually drawn on coregistered magnetic resonance images for the frontal, lateral temporal, medial temporal (MTC), parietal, and cerebellar cortices. Using the simplified reference tissue model, 5-HT(1A) binding potentials (BPs) were calculated relative to the cerebellum.

RESULTS

After adjusting for partial volume effects, ROI analysis showed a significant group effect (AD versus comparison group) on BP. Analysis of between-subjects factors showed significantly decreased 5-HT(1A) BP in the right MTC, but not in the other ROIs.

CONCLUSION

Given the strategic role of these receptors, loss of right medial temporal 5-HT(1A) receptors might play an important role in AD symptomatology.

摘要

目的

血清素-1A(5-羟色胺-1A [5-HT(1A)])受体在认知、行为及药物反应中的重要作用日益受到认可。尸检研究表明,阿尔茨海默病(AD)患者的5-HT(1A)受体减少,但这尚未在活体中得到证实。我们的主要目的是评估轻至中度AD患者中5-HT(1A)受体丧失的程度。

方法

作者使用选择性5-HT(1A)受体放射性配体[(11)C]WAY-100635,通过正电子发射断层扫描成像,对10例轻至中度AD患者和10名年龄、性别匹配的健康志愿者的5-HT(1A)受体进行了检测。在配准后的磁共振图像上,手动绘制额叶、颞叶外侧、颞叶内侧(MTC)、顶叶和小脑皮质的感兴趣区域(ROI)。使用简化参考组织模型,相对于小脑计算5-HT(1A)结合电位(BP)。

结果

校正部分容积效应后,ROI分析显示BP存在显著的组间效应(AD组与对照组)。受试者间因素分析显示,右侧MTC的5-HT(1A) BP显著降低,但其他ROI未见此现象。

结论

鉴于这些受体的关键作用,右侧颞叶内侧5-HT(1A)受体的丧失可能在AD症状学中起重要作用。

相似文献

1
A positron emission tomography study of 5-hydroxytryptamine-1A receptors in Alzheimer disease.一项关于阿尔茨海默病中5-羟色胺-1A受体的正电子发射断层扫描研究。
Am J Geriatr Psychiatry. 2007 Oct;15(10):888-98. doi: 10.1097/JGP.0b013e3180488325. Epub 2007 Jun 13.
2
Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635.通过正电子发射断层扫描术和[11C]WAY-100635测量精神分裂症患者大脑中血清素5-HT(1A)受体结合情况。
Arch Gen Psychiatry. 2002 Jun;59(6):514-20. doi: 10.1001/archpsyc.59.6.514.
3
5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction.在进行部分容积校正后,颞叶癫痫患者的5-羟色胺1A受体减少。
J Nucl Med. 2005 Jul;46(7):1128-35.
4
Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET.通过正电子发射断层扫描(PET)测量的人类大脑中5-羟色胺1A受体和5-羟色胺转运体结合的性别差异。
Neuroimage. 2008 Feb 1;39(3):1408-19. doi: 10.1016/j.neuroimage.2007.10.016. Epub 2007 Oct 25.
5
Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635.通过正电子发射断层扫描和[羰基¹¹C]WAY-100635测量神经性厌食症康复后脑5-羟色胺5-HT1A受体结合的变化。
Arch Gen Psychiatry. 2005 Sep;62(9):1032-41. doi: 10.1001/archpsyc.62.9.1032.
6
The effect of antiepileptic drugs on 5-HT-receptor binding measured by positron emission tomography.抗癫痫药物对通过正电子发射断层扫描测量的5-羟色胺受体结合的影响。
Epilepsia. 2006 Mar;47(3):499-503. doi: 10.1111/j.1528-1167.2006.00458.x.
7
Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PET.通过[11C]WAY-100635和正电子发射断层扫描(PET)测量发现,血清素5-HT1A受体结合潜能随年龄增长而下降。
Neuropsychopharmacology. 2001 May;24(5):522-30. doi: 10.1016/S0893-133X(00)00227-X.
8
Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635.精神分裂症和分裂情感性障碍患者的5-羟色胺1A受体可用性:一项使用[11C]WAY 100635的正电子发射断层扫描成像研究
Psychopharmacology (Berl). 2006 Dec;189(2):155-64. doi: 10.1007/s00213-006-0543-8. Epub 2006 Sep 5.
9
A distinct [18F]MPPF PET profile in amnestic mild cognitive impairment compared to mild Alzheimer's disease.与轻度阿尔茨海默病相比,遗忘型轻度认知障碍中独特的[18F]MPPF正电子发射断层显像特征。
Neuroimage. 2008 Apr 15;40(3):1251-6. doi: 10.1016/j.neuroimage.2008.01.030. Epub 2008 Feb 1.
10
Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635.通过正电子发射断层扫描术使用[11C]WAY-100635对康复的抑郁症男性患者进行测量,发现其大脑5-羟色胺1A受体结合持续减少。
Mol Psychiatry. 2004 Apr;9(4):386-92. doi: 10.1038/sj.mp.4001401.

引用本文的文献

1
Neurobiological and therapeutic landmarks of depression associated with Alzheimer's disease dementia.与阿尔茨海默病性痴呆相关的抑郁症的神经生物学及治疗标志
Front Aging Neurosci. 2025 Jun 2;17:1584607. doi: 10.3389/fnagi.2025.1584607. eCollection 2025.
2
State-of-the-art imaging of neuromodulatory subcortical systems in aging and Alzheimer's disease: Challenges and opportunities.神经调节亚皮质系统在衰老和阿尔茨海默病中的最新影像学研究:挑战与机遇。
Neurosci Biobehav Rev. 2023 Jan;144:104998. doi: 10.1016/j.neubiorev.2022.104998. Epub 2022 Dec 13.
3
Decreased 5-HT binding in mild Alzheimer's disease-A positron emission tomography study.
轻度阿尔茨海默病患者 5-HT 结合减少:一项正电子发射断层扫描研究。
Synapse. 2022 Jun;76(7-8):e22235. doi: 10.1002/syn.22235. Epub 2022 May 28.
4
Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer's disease.阿尔茨海默病中 5-羟色胺能药物作用的多尺度计算建模机会。
Neuropharmacology. 2020 Sep 1;174:108118. doi: 10.1016/j.neuropharm.2020.108118. Epub 2020 May 4.
5
Dysphoric symptoms in relation to other behavioral and psychological symptoms of dementia, among elderly in nursing homes.养老院老年人痴呆相关行为和心理症状以外的抑郁症状。
BMC Geriatr. 2017 Sep 7;17(1):206. doi: 10.1186/s12877-017-0603-4.
6
Molecular imaging of serotonin degeneration in mild cognitive impairment.轻度认知障碍中5-羟色胺退变的分子成像
Neurobiol Dis. 2017 Sep;105:33-41. doi: 10.1016/j.nbd.2017.05.007. Epub 2017 May 13.
7
Behavioural Phenotyping of APPswe/PS1δE9 Mice: Age-Rrelated Changes and Effect of Long-Term Paroxetine Treatment.APPswe/PS1δE9小鼠的行为表型分析:与年龄相关的变化及长期帕罗西汀治疗的影响
PLoS One. 2016 Nov 4;11(11):e0165144. doi: 10.1371/journal.pone.0165144. eCollection 2016.
8
Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.阿尔茨海默病和帕金森病神经精神症状的分子成像
Neurosci Biobehav Rev. 2015 Feb;49:157-70. doi: 10.1016/j.neubiorev.2014.11.010. Epub 2014 Nov 20.
9
A postmortem study to compare agonist and antagonist 5-HT1A receptor-binding sites in Alzheimer's disease.一项比较阿尔茨海默病中5-羟色胺1A受体激动剂和拮抗剂结合位点的尸检研究。
CNS Neurosci Ther. 2014 Oct;20(10):930-4. doi: 10.1111/cns.12306. Epub 2014 Jul 9.
10
Citalopram for agitation in Alzheimer's disease: design and methods.西酞普兰治疗阿尔茨海默病激越:设计与方法。
Alzheimers Dement. 2012;8(2):121-30. doi: 10.1016/j.jalz.2011.01.007. Epub 2012 Feb 1.